Clinical Trial 49293

Miami, FL 33186


The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.

Qualified Participants Must:

• Adults aged 40 years and older, with COPD and with chronic bronchitis
• Current smokers or ex-smokers (history of 10 pack years or higher)
• Post-bronchodilator FEV1 less than 50% of the patient predicted normal value and FEV1/FVC ratio less than 0.7
• At least, one moderate or severe COPD exacerbation in the previous year
• CAT score greater than 10
• Subjects on regular maintenance triple therapy for at least 12 months

Qualified Participants May Receive:

May receive reimbursement for time and travel for study participation, if you qualify.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.